Come up with a name for your new list and we'll add to it:
ConverGene raised a round of funding on July 23, 2013. Investors include
Maryland Technology Development Corporation.
ConverGene has discovered and developed a propriety library of small molecules that have profound effects on the MYC gene, a critical oncogene that controls progression of cancer. From this compound l…